Frank Clyburn Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Frank Clyburn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Frank Clyburn. Frank Clyburn is EVP & Pres ? Human Health in Merck & Co., Inc. ($MRK) and EVP, Chief Commercial Officer in Merck & Co., Inc. ($MRK) and Director in DuPont de Nemours, Inc. ($DWDP).
Latest Insider Trading Transactions of Frank Clyburn
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP & Pres ? Human ... | Option Exercise | M | 44.98 | 19,324 | 869,194 | 19,323 | |
May 11 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP & Pres ? Human ... | Sell | S | 78.32 | 19,324 | 1,513,440 | 94,348 | 113.7 K to 94.3 K (-17.00 %) |
May 11 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP & Pres ? Human ... | Buy | M | 0.00 | 19,324 | 0 | 113,672 | 94.3 K to 113.7 K (+20.48 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 1,906 | 0 | 0 | |
May 06 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | A | 75.99 | 131,633 | 10,002,792 | 131,633 | |
May 06 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 75.98 | 939 | 71,345 | 94,348 | 95.3 K to 94.3 K (-0.99 %) |
May 06 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 75.98 | 1,906 | 144,818 | 95,287 | 93.4 K to 95.3 K (+2.04 %) |
Apr 30 2021 | DWDP | DuPont de Nemours, ... | Clyburn Frank | Director | Grant | A | 77.05 | 2,207 | 170,049 | 8,034 | 5.8 K to 8 K (+37.88 %) |
Mar 02 2021 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Grant | A | 72.62 | 9,432 | 684,952 | 92,589 | 83.2 K to 92.6 K (+11.34 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 2,287 | 0 | 2,288 | |
Nov 03 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 75.89 | 1,137 | 86,287 | 82,519 | 83.7 K to 82.5 K (-1.36 %) |
Nov 03 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 75.89 | 2,287 | 173,560 | 83,656 | 81.4 K to 83.7 K (+2.81 %) |
Aug 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 39.29 | 18,876 | 741,638 | 0 | |
Aug 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Sell | S | 81.55 | 18,876 | 1,539,274 | 80,763 | 99.6 K to 80.8 K (-18.94 %) |
Aug 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 0.00 | 18,876 | 0 | 99,639 | 80.8 K to 99.6 K (+23.37 %) |
May 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 3,752 | 0 | 0 | |
May 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 1,904 | 0 | 1,906 | |
May 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 76.86 | 1,848 | 142,037 | 80,763 | 82.6 K to 80.8 K (-2.24 %) |
May 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 76.86 | 3,752 | 288,379 | 82,611 | 78.9 K to 82.6 K (+4.76 %) |
May 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 77.67 | 938 | 72,854 | 78,859 | 79.8 K to 78.9 K (-1.18 %) |
May 06 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 77.67 | 1,904 | 147,884 | 79,797 | 77.9 K to 79.8 K (+2.44 %) |
May 05 2020 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | A | 77.67 | 75,514 | 5,865,172 | 75,514 | |
Nov 01 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 2,287 | 0 | 4,575 | |
Nov 01 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 85.10 | 1,127 | 95,908 | 71,905 | 73 K to 71.9 K (-1.54 %) |
Nov 01 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 0.00 | 2,287 | 0 | 73,032 | 70.7 K to 73 K (+3.23 %) |
May 13 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 4,389 | 0 | 0 | |
May 13 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 78.33 | 2,162 | 169,349 | 69,831 | 72 K to 69.8 K (-3.00 %) |
May 13 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 0.00 | 4,389 | 0 | 71,993 | 67.6 K to 72 K (+6.49 %) |
May 09 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 39.29 | 25,000 | 982,250 | 18,876 | |
May 09 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Sell | S | 77.73 | 25,000 | 1,943,183 | 67,604 | 92.6 K to 67.6 K (-27.00 %) |
May 09 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 39.29 | 25,000 | 982,250 | 92,604 | 67.6 K to 92.6 K (+36.98 %) |
May 07 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 1,904 | 0 | 3,810 | |
May 07 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Option Exercise | A | 80.00 | 50,808 | 4,064,640 | 50,808 | |
May 07 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Payment of Exercise | F | 80.00 | 938 | 75,040 | 67,604 | 68.5 K to 67.6 K (-1.37 %) |
May 07 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Buy | M | 0.00 | 1,904 | 0 | 68,542 | 66.6 K to 68.5 K (+2.86 %) |
Feb 27 2019 | MRK | Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commerci ... | Grant | A | 80.38 | 4,017 | 322,886 | 66,189 | 62.2 K to 66.2 K (+6.46 %) |
Page: 1